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The prevalence rates of those who tested positive for
antihepatitis C virus and HBsAg (surface antigen of the
hepatitis B virus) were about 5e20%1 among Taiwanese
adults. Peginterferon in combination with ribavirin is
currently the standard treatment for chronic hepatitis C
infection.2 The effects of interferons include antiviral ac-
tivity, regulation of cell differentiation, enhancement of
major histocompatibility complex antigen expression, and
tumor suppression. Various dermatologic adverse effects
have been associated with interferon therapy, including
development or exacerbation of psoriasis.
We present a patient with a sudden onset of inflammation
of her numerouspreexisting solar keratoses during interferon
therapy. Our patient was a 48-year-old albino Taiwanese
woman who began a regime of weekly injection of pegin-
terferona-2b (90 mg)with daily Ribavirin for chronic hepatitis
C virus infection since February 2012. After the third injec-
tion, she noticed a pruritic eruption. An examination
revealed numerous, scaly erythematous maculopapular le-
sions distributed on the face, V-neck, and the extensor of the* Corresponding author. Department of Dermatology, National
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http://dx.doi.org/10.1016/j.jfma.2013.08.013forearms (Fig. 1A). Biopsy of a skin lesion revealed features of
solar (actinic) keratosis with a lichenoid infiltrate (Fig. 1B).
The clinical and pathologic findings were suggestive of an
interferon-induced immunologic reaction in the solar kera-
toses, which were not inflamed clinically when first seen
during a dermatology visit in 2005. Because the interferon-
induced inflammation might lead to eradication of her solar
keratoses, interferon therapy was continued. Clinical
improvement of the solar keratosis lesionswas notedwithin 4
months, which was confirmed by a follow-up skin biopsy.
Systemic chemotherapy-induced inflammation of solar
keratosis has been reported in sporadic cases, and the
drugs involved included fluorouracil, cisplatin, doxorubicin,
and vincristine.3 Of the 10 reported cases, the onset of
inflammation usually occurred early and often within days
after starting treatment. In most cases, chemotherapy was
discontinued for fear of allergy, and lesions mostly resolved
in days to weeks after drug discontinuation.
Solar keratosis, either solitary or multiple lesions, is
relatively common among elderly people with chronic sun
exposure. However, inflammation of solar keratoses during
interferon therapy is rarely reported. Sollitto et al4 re-
ported a case during fluorouracil and interferon alpha
therapy for colon cancer. Because a large number of pa-
tients in Taiwan have received interferon therapy for
chronic viral hepatitis, we suspect that such interferon-
induced inflammation of solar keratosis may not be so
rare, and that some of the cases may have been mis-
diagnosed or overlooked, particularly when solar keratosis& Formosan Medical Association. All rights reserved.
Figure 1 (A) Multiple scaly erythematous maculopapules on
bilateral upper limbs. (B) Biopsy of an erythematous lesion
reveals parakeratosis and proliferation of atypical keratino-
cytes involving the lower epidermis with a lichenoid lympho-
histiocytic infiltrate in the dermis where there is solar
elastosis. The epidermis to the right side shows confluent ne-
crosis secondary to excoriation.
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is the first reported case to demonstrate a widespread in-
flammatory reaction of solar keratoses during interferon
therapy. The present case was unusual in that the inflam-
matory rash were eruptive and widespread. Our patient had
extensive solar keratoses, which could be attributable to
her albinism. The condition made her skin depigmented and
very susceptible to sun damage, hence the early develop-
ment of a large number of solar keratoses.
DNA damage can activate innate immunity via the
stimulation of interferon-regulatory factor-1 and
interferon-regulatory factor-3, both of which can induce
expression of type I interferons. Inflammation in lesions of
solar keratosis may reflect an immunological reaction
against malignant transformed cells.5 Induction of local
inflammation and eventual resolution of solar keratoses
during interferon therapy in our patient illustrates an
antitumor effect of interferon in solar keratosis, and thus
there is no need to discontinue interferon therapy under
such clinical settings.References
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